Effects of Exposure to a Single-electrode Electroencephalography-guided Binaural Beat Audio Track on Sustained Attention and Subjective Well-being Among Healthy Adults
NCT ID: NCT07165899
Last Updated: 2025-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2024-08-16
2024-11-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improvement of Sleep Quality of Insomnia Patients with "Binaural Beats"
NCT06604208
The Impact of Twin Hearts Meditation on Mood, Cognitive Functioning, and EEG Dynamics
NCT07005830
Binaural Beat Technology and Rhythmical Photic Stimulation
NCT05666661
The BEST Study: The Efficacy of Brain Entrainment Sleep Technology in Military Healthcare Beneficiaries
NCT03169309
Somatic Tracking for Tinnitus
NCT06895824
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Electroencephalography (EEG) is a well-established technique for recording the electrical activity of the brain. This is conventionally achieved through the placement of multiple electrodes across the scalp, allowing for the detection of the brain's spontaneous electrical activity over a period of time. EEG measures voltage fluctuations resulting from ionic current flows within the neurons of the brain. Single-electrode electroencephalography simplifies the conventional approach by using one electrode placed at a strategic location on the scalp. When recorded over the pre-frontal cortex, this method allows for capturing the electrical activity of the brain's frontal lobe, which is responsible for high-level cognitive functions and behavior. EEG waves are typically divided into bandwidths known as frequency bands. These are characterized based on their frequency, which is measured in cycles per second (Hz), and include:
Delta waves (0 to 4 Hz): Associated with deep sleep and certain pathological conditions.
Theta waves (4.1 to 8 Hz): Linked to drowsiness, early stages of sleep, and meditation.
Low Alpha waves (8.1 to 10 Hz): Related to relaxed, calm, and resting states. High Alpha waves (10.1 to 14 Hz): Often associated with a state of wakeful relaxation.
Low beta waves (14.1-20 Hz): Associated with arousal, active thought, concentration, complex thought High beta waves (20.1-32 Hz): Associated with heightened arousal, hyperactive thought, hypervigilance, and states of anxiety/panic While the brain produces all of these wave types simultaneously, typically, one frequency band is dominant at any given time, reflecting the predominant brain state. For instance, during deep sleep, delta waves predominate, while during active concentration, beta waves are more prominent.
The Frequency-Following Response (FFR) is a neurophysiological mechanism where brain EEG activity synchronizes with auditory frequency stimuli. This synchronization is particularly evident with binaural beats. While many studies have supported the notion that binaural beats, via FFR, can induce desired brain states that are particularly for relaxation (e.g., increased high alpha activity), increased receptivity for hypnotic suggestions (e.g., heightened low alpha or theta activity), as well as induce sleep and improve the quality of sleep. However, other studies have challenged this notion, supported by not observing a significant FFR when the brains were stimulated for a duration of \< 5 minutes with one binaural beat frequency falling within a particular band at a given time. In fact, delivering binaural beats to participants, regardless of their current brain state, could result in discomfort, headaches, and dizziness.
The proposed study aims to overcome this limited efficacy of a static binaural beat frequency in eliciting an FFR by guiding the delivered binaural beat frequency with real-time feedback obtained from a single-electrode EEG. Based on the current biological understanding of FFR, the investigators propose to conduct a randomized, double-blinded, sham-controlled repeated-measures crossover trial to answer the following research questions:
1. Can a dynamic binaural beat frequency implemented with single-electrode EEG guidance elicit an FFR to guide the predominant EEG frequency of an individual to a target low alpha state?
2. Can a target low-alpha state achieved with the EEG feedback be sustained while the binaural beats are delivered at the target low-alpha frequency?
3. Will guiding the brain to the low-alpha state and maintaining it for up to 15 minutes in the target low-alpha state be associated with improvements in
1. subjective perception of relaxation, sleepiness, focus, performance on cognitive tasks, and overall well-being
2. objectively measured speed of reacting to stimuli, attention, inhibitory control (i.e., decreased impulsivity), and better memory encoding in a stop-signal reaction task
3. objective performance in a Go-No-Go task
4. objective performance in a graded novelty encoding task
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EEG-Guided Binaural Beat Audio
30-minute audio session with dynamic frequency adjustments based on real-time EEG feedback
EEG-Guided Binaural Beat Audio
30-minute audio session with dynamic frequency adjustments based on real-time EEG feedback
Sham Control
30-minute audio session with identical tones presented to both ears, EEG monitored but not used for frequency adjustment
Sham Control
30-minute audio session with identical tones presented to both ears (no binaural beat), EEG monitored but not used for frequency adjustment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EEG-Guided Binaural Beat Audio
30-minute audio session with dynamic frequency adjustments based on real-time EEG feedback
Sham Control
30-minute audio session with identical tones presented to both ears (no binaural beat), EEG monitored but not used for frequency adjustment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Gross visual, auditory, or motor impairments; severe physical, psychiatric, or neurological impairments
* History of epilepsy, seizures, or seizure-like episodes
* History of intracranial lesions, stroke, traumatic brain injury, neoplasms, cranial surgery, or foreign bodies
* Current daily alcohol or substance abuse
* Current daily use of medications affecting EEG activity (e.g., anti-epileptics, opioids) or lowering seizure threshold
* Self-reported auditory hypersensitivity or prior adverse effects from audio stimulation
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Texas Tech University Health Sciences Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samudani Dhanasekara
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Texas Tech University Health Sciences Center, Lubbock, TX, USA
Lubbock, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-FY2024-286
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.